Table 2.

Timing of maintenance CAB + RPV LA injections over follow-up, overall, and by viral load at initiation

	Overall N = 321	< 50 copies/mL N = 273	≥ 50 copies/mL N = 43
Median months of follow-up (IQR)	4.2 (2.7, 6.8)	4.1 (2.5, 6.4)	4.7 (3.0, 7.5)
Median number of continuation injections per person (IQR)	3 (2, 5)	3 (2, 5)	3 (1, 6)
CAB + RPV LA discontinuation, n (%)	42 (13)	33 (12)	9 (21)
Individuals with ≥ 1 delay, n (%)	75 (23)	65 (23)	9 (21)
Median # delays per person (IQR)	1 (1, 2)	1 (1, 1)	2 (1, 3)
Median days after target date, if delayed injection (IQR)	24 (13, 31)	22 (12, 31)	24 (19, 31)
Individuals with ≥ 2 continuation injections, n (%)	241 (75)	205 (75)	31 (72)
Individuals with ≥ 2 delays, n (%)	19 (8)	14 (7)	5 (16)
Individuals with ≥ 2 sequential delays, n (%)	13 (5)	5 (2)	4 (13)

IQR interquartile range, Nn number